These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 16207186)

  • 1. Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Int J Dermatol; 2005 Oct; 44(10):841-5. PubMed ID: 16207186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable vitiligo treated by a combination of low-dose oral pulse betamethasone and autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Dermatol Surg; 2006 Apr; 32(4):536-41. PubMed ID: 16681662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous melanocyte-keratinocyte suspension in the treatment of vitiligo.
    El-Zawahry BM; Zaki NS; Bassiouny DA; Sobhi RM; Zaghloul A; Khorshied MM; Gouda HM
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):215-20. PubMed ID: 20569286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
    Mulekar SV; Al Issa A; Al Eisa A
    Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanocyte-keratinocyte cell transplantation for stable vitiligo.
    Mulekar SV
    Int J Dermatol; 2003 Feb; 42(2):132-6. PubMed ID: 12709002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melanocyte-keratinocyte transplantation procedure in the treatment of vitiligo: the experience of an academic medical center in the United States.
    Huggins RH; Henderson MD; Mulekar SV; Ozog DM; Kerr HA; Jabobsen G; Lim HW; Hamzavi IH
    J Am Acad Dermatol; 2012 May; 66(5):785-93. PubMed ID: 21864935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population.
    Toossi P; Shahidi-Dadras M; Mahmoudi Rad M; Fesharaki RJ
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1182-6. PubMed ID: 21214632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
    Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
    J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous melanocyte transfer via epidermal grafts for lip vitiligo.
    Gupta S; Goel A; Kanwar AJ; Kumar B
    Int J Dermatol; 2006 Jun; 45(6):747-50. PubMed ID: 16796641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of vitiligo lesions by ReCell vs. conventional melanocyte-keratinocyte transplantation: a pilot study.
    Mulekar SV; Ghwish B; Al Issa A; Al Eisa A
    Br J Dermatol; 2008 Jan; 158(1):45-9. PubMed ID: 17927795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
    Issa CM; Rehder J; Taube MB
    Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up.
    Vázquez-Martínez OT; Martínez-Rodríguez HG; Velásquez-Arenas L; Baños-González D; Ortíz-López R; Padilla-Rivas G; Welsh O; Ocampo-Candiani J
    J Drugs Dermatol; 2011 Sep; 10(9):1032-6. PubMed ID: 22052273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of 2-mm punch grafting in patients with vitiligo vulgaris and segmental vitiligo: effect of disease activity.
    Fongers A; Wolkerstorfer A; Nieuweboer-Krobotova L; Krawczyk P; Tóth GG; van der Veen JP
    Br J Dermatol; 2009 Nov; 161(5):1105-11. PubMed ID: 19673878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation.
    Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE
    Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents.
    Sahni K; Parsad D; Kanwar AJ
    Clin Exp Dermatol; 2011 Aug; 36(6):607-12. PubMed ID: 21507039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noncultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo.
    Mohanty S; Kumar A; Dhawan J; Sreenivas V; Gupta S
    Br J Dermatol; 2011 Jun; 164(6):1241-6. PubMed ID: 21275943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of autologous transplantation of noncultured epidermal suspension in two different dilutions in the treatment of vitiligo.
    Tegta GR; Parsad D; Majumdar S; Kumar B
    Int J Dermatol; 2006 Feb; 45(2):106-10. PubMed ID: 16445497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repigmentation in vitiligo patients. Melanocyte transfer via ultra-thin grafts.
    Kahn AM; Cohen MJ
    Dermatol Surg; 1998 Mar; 24(3):365-7. PubMed ID: 9537012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-engineered skin in the treatment of vitiligo lesions.
    Arenberger P; Broz L; Veselý P; Havlícková B; Matousková E
    Folia Biol (Praha); 2000; 46(4):157-60. PubMed ID: 10954161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.